Clinical trial

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

NCT01326533

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE4

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2016-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pre-diabetesunresolved

Interventions

hydroxychloroquineDRUG · verified · RxNorm: hydroxychloroquine

PlaceboOTHER

Sponsors & collaborators

University of Pittsburghlead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01326533 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.